Hochschulschrift
Parenteral drug delivery systems based on fatty acid modified poly(glycerol adipate)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Halle (Saale), Universitäts- und Landesbibliothek Sachsen-Anhalt, Diss., 2014
- Keyword
-
Arzneimittelentwicklung
Arzneimitteldesign
- Event
-
Veröffentlichung
- (where)
-
Halle, Saale
- (who)
-
Universitäts- und Landesbibliothek Sachsen-Anhalt
- (when)
-
2014
- Creator
-
Weiss, Verena Maria
- Contributor
- URN
-
urn:nbn:de:gbv:3:4-11894
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
- Weiss, Verena Maria
- Mäder, Karsten
- Kressler, Jörg
- Schulz-Siegmund, Michaela
- Universitäts- und Landesbibliothek Sachsen-Anhalt
Time of origin
- 2014
Other Objects (12)
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Benefits of ω-3 fatty acids in parenteral nutrition
Glycerol‑bound oxidized fatty acids : formation and occurrence in peanuts
Poly(glycerol adipate) - indomethacin conjugates for modified drug release
Supplementation of Ω-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern
Oil-based parenteral depot formulation for veterinary peptide delivery
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
In situ forming biodegradable microparticles for sustained parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Benefits of ω-3 fatty acids in parenteral nutrition
Glycerol‑bound oxidized fatty acids : formation and occurrence in peanuts
Poly(glycerol adipate) - indomethacin conjugates for modified drug release
Supplementation of Ω-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern
Oil-based parenteral depot formulation for veterinary peptide delivery
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
In situ forming biodegradable microparticles for sustained parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Benefits of ω-3 fatty acids in parenteral nutrition
Glycerol‑bound oxidized fatty acids : formation and occurrence in peanuts
Poly(glycerol adipate) - indomethacin conjugates for modified drug release
Supplementation of Ω-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern
Oil-based parenteral depot formulation for veterinary peptide delivery
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Challenging controlled drug delivery : matrix systems for oral and parenteral application
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
In situ forming biodegradable microparticles for sustained parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery